Announcing the InCELL Pulse™ target engagement platform
Announcing the launch of the SAFETYscan™ in vitro pharmacological profiling services
Announcing PathHunter® β-Arrestin Retroparticles
Announcing the launch of the KILR™ Retropartices
DiscoverX partners with the Structural Genomics Consortium (SGC)
Announcing the launch of the KILR™ Cytotoxicity Assay
Announcing the launch of PathHunter® Checkpoint Assays
PathHunter® portfolio expansion with Interleukin cell-based assays
Primary Human Cell Models Identify Potential Safe and Efficacious Drug Combinations